Drugs / Fluorothyazinone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03205462 | Aug → Dec 2017 | — | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluorothyazinone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03205462 ↗ |
| Route | Oral | “received per os (oral administration) as a single dose” NCT03205462 ↗ |